LRIG1 and acute myeloid leukemia: In conclusion, findings obtained in the current study demonstrated that AML cell-derived EVs carrying miR-1246 activated the STAT3 pathway by targeting LRIG1, thereby promoting LSCs viability and colony formation ability, while inhibiting cell apoptosis and differentiation, ultimately augmenting the survival of LSCs (Figure 8).